9 research outputs found

    Algorithms for diagnosing tuberculosis with and without a nucleic acid amplification test and associated resources consumed.

    No full text
    <p>Definition of abbreviations: AFBā€Š=ā€ŠAcid-fast bacillus; AIIā€Š=ā€Šairborne infection isolation; NAATā€Š=ā€Šnucleic acid amplification test; TBā€Š=ā€Štuberculosis. Legend: The squares represent decision nodes, circles a chance node, and triangles a terminal node. Each condition represents the sequence of events that may occur to patients with an AFB smear-positive respiratory specimen. Using cost inputs described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100649#pone-0100649-t001" target="_blank">Table 1</a>, we compared average cost per patient under each condition: ā€œNAAT conditionsā€ versus ā€œno NAAT conditionsā€.</p

    Model parameters, base case and reasonable ranges.

    No full text
    <p>AFBā€Š=ā€ŠAcid fast bacillus; AIIā€Š=ā€Šairborne infection isolation; GMHā€Š=ā€ŠGrady Memorial Hospital, Atlanta, GA, USA; NAATā€Š=ā€Šnucleic acid amplification test; PPVā€Š=ā€Špositive predictive value; TBā€Š=ā€Štuberculosis</p><p>*Base case was determined by multiplying charge by cost/charge ratio.</p><p>āˆ§This upper bound was determined in the cited publication by considering all aspects of outpatient care in calculating treatment cost and was included for sensitivity analyses.</p>ā€ <p>We could not find estimates of exposure investigation cost in the literature, so for sensitivity analyses we took the extreme position of varying the cost from one tenth to 100 times the base case cost (for low and high bounds, respectively).</p>ā€”<p>TB prevalence among patients in our study population, i.e. those with an AFB smear-positive sputum sample. This is equivalent to the PPV of AFB smear microscopy.</p><p>#The TB prevalence among AFB smear positives in our study (i.e. PPV of AFB smear) was lower than any found in the literature. For lower bound of TB prevalence we used PPV among HIV patients in our study, i.e. as if all AFB smear-positive patients had HIV.</p

    Performance of a nucleic acid amplification test (NAAT) on AFB smear-positive respiratory specimens stratified by HIV status.

    No full text
    <p>AFBā€Š=ā€ŠAcid-fast bacillus; HIV+ā€Š=ā€ŠHIV seropositive; HIV-ā€Š=ā€ŠHIV seronegative; NAATā€Š=ā€Šnucleic acid amplification test; NPVā€Š=ā€Šnegative predictive value; PPVā€Š=ā€Špositive predictive value; TBā€Š=ā€Štuberculosis; +ā€Š=ā€Špositive; āˆ’ā€Š=ā€Šnegative.</p

    Positive predictive value of an AFB smear-positive respiratory specimen for culture-confirmed tuberculosis stratified by HIV status.

    No full text
    <p>AFBā€Š=ā€ŠAcid-fast bacillus; HIV+ā€Š=ā€ŠHIV-seropositive; HIV -ā€Š=ā€Š HIV-seronegative; NTMā€Š=ā€Šnon-tuberculous mycobacteria; PPVā€Š=ā€Špositive predictive value; TBā€Š=ā€Štuberculosis</p

    Performance parameters of MTBDR<i>plus</i> in detecting INH R<sup>āˆ§</sup>, RIF R<sup>āˆ§</sup>, and MDR<sup>āˆ§</sup> compared to conventional DST (reference standard)<sup>#</sup>.

    No full text
    #<p>Values are percentages with 95% confidence interval in parentheses.</p><p>*PPVā€Š=ā€Špositive predictive value, NPVā€Š=ā€Šnegative predictive value.</p>āˆ§<p>INH Rā€Š=ā€Šisoniazid resistance, RIF Rā€Š=ā€Šrifampin resistance, MDRā€Š=ā€Šmultidrug resistance.</p
    corecore